RENAL TOXICITY OF PEMETREXED IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Inoue, Y. [1 ]
Karayama, M. [1 ]
Ito, Y. [1 ]
Kusagaya, H. [1 ]
Matsuura, S. [1 ]
Nakamura, Y. [1 ]
Inui, N. [1 ]
Suda, T. [1 ]
机构：
[1] Hamamatsu Univ, Dept Internal Med, Sch Med, Div 2, Hamamatsu, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt460.16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [21] Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
    Minami, Seigo
    Kijima, Takashi
    LUNG CANCER-TARGETS AND THERAPY, 2015, 6 : 13 - 25
  • [22] Pemetrexed for non-squamous non-small-cell lung cancer: experience in Northern Ireland
    Mulligan, C.
    Campbell, L.
    McAleese, J.
    Scullin, P.
    LUNG CANCER, 2011, 71 : S6 - S6
  • [23] Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer
    Stinchcombe, Thomas E.
    Borghaei, Hossein
    Barker, Scott S.
    Treat, Joseph Anthony
    Obasaju, Coleman
    CLINICAL LUNG CANCER, 2016, 17 (01) : 1 - 9
  • [24] Dexamethasone alleviates pemetrexed-induced senescence in Non-Small-Cell Lung Cancer
    Ge, Haiyan
    Ke, Jun
    Xu, Nuo
    Li, Hongqing
    Gong, Jin
    Li, Xiangyang
    Song, Yuanlin
    Zhu, Huili
    Bai, Chunxue
    FOOD AND CHEMICAL TOXICOLOGY, 2018, 119 : 86 - 97
  • [25] Reality Check for Pemetrexed and Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer
    Murray, Nevin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (05) : 482 - 483
  • [26] A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer
    Kotsakis, Athanasios
    Agelaki, Sophia
    Vardakis, Nikolaos
    Stathopoulos, George
    Vamvakas, Lambros
    Kalykaki, Antonia
    Kentepozidis, Nikolaos
    Kontopodis, Emmanouel
    Sfakiotaki, Georgia
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 415 - 422
  • [27] Pemetrexed in Nonsquamous Non-Small-Cell Lung Cancer The Billion Dollar Subgroup Analysis
    Gyawali, Bishal
    Prasad, Vinay
    JAMA ONCOLOGY, 2018, 4 (01) : 17 - 18
  • [28] A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer
    Athanasios Kotsakis
    Sophia Agelaki
    Nikolaos Vardakis
    George Stathopoulos
    Lambros Vamvakas
    Antonia Kalykaki
    Nikolaos Kentepozidis
    Emmanouel Kontopodis
    Georgia Sfakiotaki
    Dimitris Mavroudis
    Vassilis Georgoulias
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 415 - 422
  • [29] Patterns of renal toxicity from the combination of pemetrexed and pembrolizumab for advanced nonsquamous non-small-cell lung cancer (NSCLC): A single-center experience
    De Giglio, Andrea
    Grandinetti, Valeria
    Aprile, Marta
    Borelli, Greta
    Campus, Anita
    Chiocchini, Anna Laura Croci
    Busutti, Marco
    Vischini, Gisella
    Di Federico, Alessandro
    Sperandi, Francesca
    Melotti, Barbara
    Ardizzoni, Andrea
    La Manna, Gaetano
    Gelsomino, Francesco
    LUNG CANCER, 2022, 174 : 91 - 96
  • [30] Pemetrexed Use in the Adjuvant Setting for Completely Resectable Non-Small-Cell Lung Cancer
    Simon, George R.
    Manegold, Christian
    Barker, Scott S.
    Treat, Joseph A.
    Visseren-Grul, Carla
    Obasaju, Coleman
    CLINICAL LUNG CANCER, 2013, 14 (06) : 601 - 608
12345